InChI=1S/C28H48N2O21/c1- 7(34) 29- 13- 17(38) 23(10(4- 32) 46- 25(13) 44) 50- 28- 22(43) 20(41) 16(37) 12(49- 28) 6- 45- 26- 14(30- 8(2) 35) 18(39) 24(11(5- 33) 48- 26) 51- 27- 21(42) 19(40) 15(36) 9(3- 31) 47- 27/h9- 28,31- 33,36- 44H,3- 6H2,1- 2H3,(H,29,34) (H,30,35) /t9- ,10- ,11- ,12- ,13- ,14- ,15+,16+,17- ,18- ,19+,20+,21- ,22- ,23- ,24- ,25- ,26+,27+,28+/m1/s1 |
SVIRFPAAZYGYOL-KXGFIOBDSA-N |
CC(=O) N[C@H] 1[C@H] (O) O[C@H] (CO) [C@@H] (O[C@@H] 2O[C@H] (CO[C@H] 3O[C@H] (CO) [C@@H] (O[C@@H] 4O[C@H] (CO) [C@H] (O) [C@H] (O) [C@H] 4O) [C@H] (O) [C@H] 3NC(C) =O) [C@H] (O) [C@H] (O) [C@H] 2O) [C@@H] 1O |
|
epitope
The biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds.
|
|
View more via ChEBI Ontology
Outgoing
|
β- D- Galp- (1→4)- α- D- GlcpNAc- (1→6)- β- D- Galp- (1→4)- β- D- GlcpNAc
(CHEBI:70849)
has role
epitope
(CHEBI:53000)
β- D- Galp- (1→4)- α- D- GlcpNAc- (1→6)- β- D- Galp- (1→4)- β- D- GlcpNAc
(CHEBI:70849)
is a
amino tetrasaccharide
(CHEBI:59412)
β- D- Galp- (1→4)- α- D- GlcpNAc- (1→6)- β- D- Galp- (1→4)- β- D- GlcpNAc
(CHEBI:70849)
is a
glucosamine oligosaccharide
(CHEBI:22485)
|
|
β- D- galactopyranosyl- (1→4)- 2- acetamido- 2- deoxy- α- D- glucopyranosyl- (1→6)- β- D- galactopyranosyl- (1→4)- 2- acetamido- 2- deoxy- β- D- glucopyranose
|
β- D- Gal- (1→4)- α- D- GlcNAc- (1→6)- β- D- Gal- (1→4)- β- D- GlcNAc
|
ChEBI
|
β- D- galactosyl- (1→4)- 2- acetamido- 2- deoxy- α- D- glucosyl- (1→6)- β- D- galactosyl- (1→4)- 2- acetamido- 2- deoxy- β- D- glucose
|
ChEBI
|
β- D- galactosyl- (1→4)- N- acetyl- α- D- glucosaminyl- (1→6)- β- D- galactosyl- (1→4)- N- acetyl- β- D- glucosamine
|
ChEBI
|
Galb1-4GlcNAca1-6Galb1-4GlcNAcb
|
ChEBI
|
Galβ1-4GlcNAcα1-6Galβ1-4GlcNAcβ
|
ChEBI
|
WURCS=2.0/3,4,3/[a2122h- 1b_1- 5_2*NCC/3=O][a2112h- 1b_1- 5][a2122h- 1a_1- 5_2*NCC/3=O]/1- 2- 3- 2/a4- b1_b6- c1_c4- d1
|
GlyTouCan
|
|